Hope Cain et al. [55] achieved an AUC value of 0.71 (95% CI: 0.58–0.83) for predicting pCR to NST in TN/HER2+ breast cancer patients; however, the model was not externally validated. This evidence concerns the gene ERBB2 and breast carcinoma.